Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Aug 06, 2021 12:23pm
553 Views
Post# 33663635

TLD1433 versus the Flu

TLD1433 versus the FluUM Today News

Tolani Olanrewaju, a 4th year University of Manitoba honours microbiology student who came to Canada from Nigeria in high school, is researching the inactivation of influenza by TLD1433 photodynamic therapy. She will be presenting her research in a three-minute or less undergraduate competition that will be available to view on the UM Faculty of Science YouTube channel on August 10.

Go Tolani !

3MT Competition: Life Sciences 2021

 
Cheer on the Faculty of Science 3MT 2021 Competitors
 
AUGUST 6, 2021 — 
Students will be challenged to showcase their research to a general audience in a three-minute or less, 3MT competition – August 10th, & 11th, 2021. Part of the Faculty of Science, Student Undergraduate Summer Research Experience Program.
 
There will be two competitions that will air live on the Faculty of Science YouTube channel.
 
- Life Sciences
Tuesday, August 10, at 1 PM: Watch online: https://youtu.be/SNNuIyD3KVY 
 
- Physical Science and Computational & Data Sciences
Wednesday, August 11, at 1 PM: Watch online: https://youtu.be/8jOZRoIlQfs  
 
Tune in, and cheer on our undergraduate students! Discover world-changing research at the UM Faculty of Science.
 
Life Sciences
3MT Competition
Tuesday August 10, 2021 at 1:00 pm
 
Watch online: https://youtu.be/SNNuIyD3KVY 
 
.............................................
 
Photodynamic Inactivation Effect on Influenza using TLD-1433 as a Photosensitizer
Tolani Olanrewaju 
Supervisor: Dr. Kevin Coombs, Department of Microbiology 
<< Previous
Bullboard Posts
Next >>